150 related articles for article (PubMed ID: 27565892)
21. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
22. Pediatric rhabdomyosarcoma of the head and neck.
Gillespie MB; Marshall DT; Day TA; Mitchell AO; White DR; Barredo JC
Curr Treat Options Oncol; 2006 Jan; 7(1):13-22. PubMed ID: 16343365
[TBL] [Abstract][Full Text] [Related]
23. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
25. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
27. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
[TBL] [Abstract][Full Text] [Related]
28. The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases.
Fayda M; Aksu G; Yaman Agaoglu F; Karadeniz A; Darendeliler E; Altun M; Hafiz G
J Craniomaxillofac Surg; 2009 Jan; 37(1):42-8. PubMed ID: 18804382
[TBL] [Abstract][Full Text] [Related]
29. New combined treatment of surgery, radiotherapy, and reconstruction in head and neck rhabdomyosarcoma in children: the AMORE protocol.
Schouwenburg PF; Kupperman D; Bakker FP; Blank LE; de Boer HB; Voûte TA
Head Neck; 1998 Jul; 20(4):283-92. PubMed ID: 9588699
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of induction chemotherapy as a selection marker for chemoradiation in the head and neck.
Kiong KL; de Souza NN; Sultana R; Iyer NG
Laryngoscope; 2018 Jul; 128(7):1594-1601. PubMed ID: 29171671
[TBL] [Abstract][Full Text] [Related]
32. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
[TBL] [Abstract][Full Text] [Related]
33. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.
Song S; Wu HG; Lee CG; Keum KC; Kim MS; Ahn YC; Oh D; Park HJ; Lee SW; Park G; Moon SH; Cho KH; Kim YS; Won Y; Oh YT; Kim WT; Jeong JU
BMC Cancer; 2017 Aug; 17(1):598. PubMed ID: 28854890
[TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J
Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841
[TBL] [Abstract][Full Text] [Related]
36. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
[TBL] [Abstract][Full Text] [Related]
37. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
38. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study.
Chougule PB; Suk S; Chu QD; Leone L; Nigri PT; McRae R; Lekas M; Barone A; Bhat D; Bellino J
Cancer; 1994 Oct; 74(7):1927-32. PubMed ID: 8082098
[TBL] [Abstract][Full Text] [Related]
40. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Okano S; Enokida T; Onoe T; Ota Y; Motegi A; Zenda S; Akimoto T; Tahara M
Int J Clin Oncol; 2019 Jul; 24(7):789-797. PubMed ID: 30796560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
